Lifevantage (LFVN) Liabilities and Shareholders Equity (2011 - 2026)

Lifevantage has reported Liabilities and Shareholders Equity for 16 years, with the latest figure at $62.1 million in Q1 2026.

• For the quarter ending Q1 2026, Liabilities and Shareholders Equity fell 19.56% year-over-year to $62.1 million; the trailing twelve-month figure through Mar 2026 stood at $256.8 million (down 4.0% YoY), and the FY2025 full-year result was $72.0 million, up 19.34% from the prior year.
• Liabilities and Shareholders Equity for Q1 2026 stood at $62.1 million, up from $61.2 million in the prior quarter.
• The five-year high for Liabilities and Shareholders Equity was $77.2 million in Q1 2025, with the low at $60.3 million in Q2 2024.
• Historically, Liabilities and Shareholders Equity has averaged $66.3 million across 5 years, with a median of $66.6 million in 2023.
• Annual changes were most pronounced in 2025 — Liabilities and Shareholders Equity grew 25.98% — and 2026, when it decreased 19.56%.
• Lifevantage's Liabilities and Shareholders Equity stood at $67.8 million in 2022, then dropped by 7.59% to $62.7 million in 2023, then rose by 9.32% to $68.5 million in 2024, then fell by 10.74% to $61.2 million in 2025, then advanced by 1.57% to $62.1 million in 2026.
• The last three Liabilities and Shareholders Equity figures came in at $62.1 million (Q1 2026), $61.2 million (Q4 2025), and $61.6 million (Q3 2025), per Business Quant data.